Učitavanje...
Neprilysin inhibition in chronic kidney disease
Despite current practice, patients with chronic kidney disease (CKD) are at increased risk of progression to end-stage renal disease and cardiovascular events. Neprilysin inhibition (NEPi) is a new therapeutic strategy with potential to improve outcomes for patients with CKD. NEPi enhances the activ...
Spremljeno u:
| Izdano u: | Nephrol Dial Transplant |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4425478/ https://ncbi.nlm.nih.gov/pubmed/25140014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfu269 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|